William Sumner DeWitt, Iii

Title: William Sumner DeWitt, III: Innovator in Immunology

Introduction

William Sumner DeWitt, III is a notable inventor based in Seattle, WA. He has made significant contributions to the field of immunology, particularly in understanding adaptive immune responses. His work has implications for vaccination and infection monitoring, showcasing the intersection of technology and healthcare.

Latest Patents

William Sumner DeWitt, III holds a patent titled "Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing." This patent focuses on methods for monitoring and measuring dynamic adaptive immune cell responses. High-throughput sequencing of T cell receptor and immunoglobulin loci is utilized to characterize the breadth of an effector cell response to stimuli such as vaccines or infections. The patent also details how unique responding effector cell clones and their abundance can be determined. Furthermore, it provides methods for assessing the contribution of responding effector cells to the immunological memory compartment.

Career Highlights

Throughout his career, DeWitt has worked with prominent organizations in the field of biotechnology and cancer research. He has been associated with Adaptive Biotechnologies Corporation, where he contributed to advancements in immune profiling. Additionally, he has worked at the Fred Hutchinson Cancer Center, a leading research institution focused on cancer and related diseases.

Collaborations

DeWitt has collaborated with esteemed colleagues, including Harlan Saul Robins and Ryan O Emerson. Their collective expertise has furthered research in adaptive immunity and its applications in clinical settings.

Conclusion

William Sumner DeWitt, III is a pioneering inventor whose work in immunology has the potential to transform how we understand and respond to infections and vaccinations. His contributions through patents and collaborations highlight the importance of innovation in healthcare.